VSY Biotechnology Revenue

Medical Equipment Manufacturing • Leinfelden-Echterdingen, Baden-Württemberg, Germany • 101-200 Employees

VSY Biotechnology revenue & valuation

Annual revenue	$6,038,958
Revenue per employee	$32,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$19,400,000
Total funding	No funding

Key Contacts at VSY Biotechnology

Ahmed Said

Global Sales Director Medical Aesthetics,Emea,Apac,Na&Latam

Haitham Sayed

Regional Director - Mea

Christian Bach

Managing Director

Berna Ozel Guvensan

Corporate Communication & Marketing Director

Rajesh Sharma

Director

Company overview

Headquarters	Esslingerst. 7 70771, Leinfelden-Ecterdingen, Germany, Leinfelden-Ecterdingen, DE
Phone number	+49711997606333
Website	vsybiotechnology.com
NAICS	3391
SIC	873
Keywords	Ophthalmology, Cataract, Intra Ocular Lenses, Premium Iols, Viscoelastics, Balanced Salt Solution, Intra Articular Injections
Founded	2009
Employees	101-200
Socials

VSY Biotechnology Email Formats

VSY Biotechnology uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@vsybiotechnology.com), used 43% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@vsybiotechnology.com	43%
{first name}.{last name}	john.doe@vsybiotechnology.com	40.7%
{first initial}{last name}	jdoe@vsybiotechnology.com	8.1%
{first initial}.{last name}	j.doe@vsybiotechnology.com	3.5%
{last name}{last name}	doedoe@vsybiotechnology.com	2.3%

About VSY Biotechnology

As VSY Biotechnology we are a progressive and innovative company that focuses on customer satisfaction by creating superior state of the art ophthalmology products designed and manufactured to greatly enhance and improve vision for our wide range of patients around the globe. All our products go through rigorous and comprehensive research and development to ensure manufacturing efficiency and the highest optic quality. With our superior product line and our sterling focus on our customers needs, we at VSY Biotechnology believe that the future could not be clearer. VSY Biotechnology focuses on cataract products and developing improvements to existing intraocular lens models. We deliver our technologies through two complementary product lines, each providing specific solutions to address ophthalmologist's and patients' needs. Thanks to its advanced technology, VSY Biotechnology presents monofocal and multifocal IOLs in different platforms (Modified C, Balance and Plate Haptic). Beside those products the company has foldable scleral fixation lens. Beside intraocular lenses VSY Biotechnology also manufactures viscoelastics and injector and cardridge systems for cataract surgery. Customer satisfaction and trust are the foundation of VSY Biotechnology. We believe that our customers come first. We manufacture and produce innovative ophthalmology products and brands that are at the forefront of the world wide global market in pursuit of total customer satisfaction.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Manager

Senior

Employees by Department

VSY Biotechnology has 75 employees across 12 departments.

Departments

Number of employees

Funding Data

VSY Biotechnology has never raised funding before.

VSY Biotechnology Tech Stack

Discover the technologies and tools that power VSY Biotechnology's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

CDN

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Drupal

CMS

RSS

Miscellaneous

jsDelivr

CDN

Linkedin Insight Tag

Analytics

Microsoft 365

Frequently asked questions

VSY Biotechnology is located in Leinfelden-Echterdingen, Baden-Württemberg, DE.

You can reach VSY Biotechnology at +49711997606333.

VSY Biotechnology generates an estimated annual revenue of $6,038,958. This revenue figure reflects the company's market position and business performance in its industry.

VSY Biotechnology has an estimated valuation of $19,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

VSY Biotechnology was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

VSY Biotechnology has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.